HOME ZACKS RESEARCH FUNDS PORTFOLIO BROKER RESEARCH MARKETS SCREENING EDUCATION SERVICES
Zacks Rank    Equity Research    Premium Home    My Account    Help    


Top Stocks Set to Outperform
Over the Next 1 to 3 Months.

Click for your free picks >>

Quote:
Login Free Membership
Search:

 
Analyst Blog  

ArthroCare Downgraded to Hold

October 06, 2008 | Comments: 0
Recommended this article (1)
Print    Share

The near-term should be difficult for ArthroCare Corp. (ARTC - Analyst Report) investors as the company navigates the delayed filing of financial statements, FBI probe, and class action suits. The Centers for Medicare and Medicaid Services’ non-coverage determination combined with the DiscoCare litigation will likely damage the Spine segment. Our recommendation moves to Hold.

The company’s clear strategy to leverage its patented Coblation technology and other innovative, clinically superior surgical devices for the surgical treatment of soft-tissue conditions should help pull them through this difficult time. New products in Sports Medicine are stimulating growth in a fairly mature segment. Oncology also represents another growth opportunity for the company.

Given the current headline risk, we are surprised that the company trades at an 8% premium to the average of comparables 1.2x 2008 P/E/G. We believe most health plans and governments will seek to cut costs. We are adjusting our estimates to reflect the potential fallout as the management is diverted from normal business operations. Using a blend of P/S and P/E/G, we value the stock at $33.

Read the full analyst report on ARTC


Email

Print

Share

RSS

Rate Pos

Rate Neg

Comment
Read/Post Comments (0) | Recommended this article (1)
 Posting Comment...
There was a problem posting this this comment. Please try back later.
[CLICK TO CLOSE X]
Comments (Limit 1000 Characters - Used: 0)
Display Name: Email Address:  
 Loading Comments...
Be the first to comment on this article!
Best Stocks. Best Insight. Join Now...it's FREE!
Over 550,000 investors look forward to the timely insights in our email newsletter; Zacks Profit from the Pros. In each daily issue you will find:
  • Free  Four Zacks #1 Rank "Strong Buy" Stocks
  • Free  Timely Market Commentary
  • Free  Wealth Management Tips
  • Free  Profitable Strategy Screens
  • Free  Bull and Bear Stocks of the Day
Zacks FREE Registration

More Zacks Resources

Market Summary Nov 26, 2009 12:20 pm ET
DJIA 10464.4  30.69 0.29%
NASD 2176.05  6.87 0.32%
S&P 500 1110.63  4.98 0.45%
Sponsored Links